Nw-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: Nw-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.
Authors: Mohan S; University of New England, Portland, Maine, USA., Van Pelt DW; MaineHealth Cancer Care Network, Scarborough, Maine, USA., Saunders JG; MaineHealth Institute for Research, Scarborough, Maine, USA., DiPalazzo J; MaineHealth Institute for Research, Scarborough, Maine, USA., Monahan SE; MaineHealth Institute for Research, Scarborough, Maine, USA., Buchsbaum RJ; Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, USA., Frankenfeld CL; MaineHealth Institute for Research, Scarborough, Maine, USA.; Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, USA., Bertaux BY; University of New England, Portland, Maine, USA., Miesfeldt S; MaineHealth Cancer Care Network, Scarborough, Maine, USA.; MaineHealth Institute for Research, Scarborough, Maine, USA.; Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, USA.
Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2026 Jul; Vol. 9 (7), pp. e70609.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2573-8348
DOI:10.1002/cnr2.70609